Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant Neoplasms
|
1641 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.050 | 1.000 | 5 | 2012 | 2017 | |||||
Primary malignant neoplasm
|
1374 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.050 | 1.000 | 5 | 2012 | 2017 | |||||
Xeroderma pigmentosum, group G
|
31 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.040 | 1.000 | 4 | 2016 | 2017 | |||||
Malignant neoplasm of stomach
|
615 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.030 | 1.000 | 3 | 2012 | 2019 | |||||
Stomach Carcinoma
|
652 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.030 | 1.000 | 3 | 2012 | 2019 | |||||
Malignant neoplasm of prostate
|
1082 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.020 | 1.000 | 2 | 2013 | 2014 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.020 | 1.000 | 2 | 2013 | 2015 | |||||
Prostate carcinoma
|
1168 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.020 | 1.000 | 2 | 2013 | 2014 | |||||
Breast Carcinoma
|
2793 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Childhood Osteosarcoma
|
151 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Colorectal Carcinoma
|
1962 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Esophageal carcinoma
|
272 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Esophageal Neoplasms
|
270 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Malignant neoplasm of breast
|
3417 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Malignant neoplasm of esophagus
|
214 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Osteosarcoma
|
178 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Osteosarcoma of bone
|
151 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Progressive cGVHD
|
40 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Progressive Neoplastic Disease
|
40 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Squamous cell carcinoma of esophagus
|
329 | 0.695 | 0.280 | 13 | 102846025 | 5 prime UTR variant | T/C | snv | 0.38 | 0.010 | 1.000 | 1 | 2012 | 2012 |